Rabinab Tablet

Rabinab Tablet belongs to a group of antiulcer medicines called proton pump inhibitors used to treat duodenal ulcers, gastro-oesophageal reflux disease (reflux of gastric contents into the oesophagus), heartburn, erosive oesophagitis (acid-related damage to the lining of the oesophagus), infections caused by Helicobacter pylori when given along with an antibiotic, and Zollinger-Ellison syndrome.

Rabinab Tablet contains 'Rabeprazole' that works by blocking the action of the enzyme known as gastric proton pump which is responsible for the production of acid. This helps in reducing the amount of acid produced, heals the ulcers and prevents the formation of new ulcers.

You are advised to take Rabinab Tablet for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, you may experience certain common side-effects such as headache, dizziness, diarrhoea, constipation, nausea, vomiting, flatulence (wind), weakness, and runny nose. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.

Inform your doctor if you have a stomach tumour or liver disease. On long-term treatment, Rabinab Tablet may cause low magnesium levels, vitamin B12 levels and increase the risk of bone fractures. Consult your doctor if you are pregnant or breastfeeding. Rabinab Tablet may cause dizziness and sleepiness, so drive only if you are alert. Rabinab Tablet is not recommended for children as safety has not been established. Avoid consuming alcohol along with Rabinab Tablet as it could lead to increased drowsiness and can elevate the production of stomach acid.

Rabinab Tablet belongs to a group of antiulcer medicines called proton pump inhibitors. Rabinab Tablet is used to treat duodenal ulcers, gastro-oesophageal reflux disease (reflux of gastric contents into the oesophagus), heartburn, erosive oesophagitis (acid-related damage to the lining of the oesophagus), infections caused by Helicobacter pylori when given along with an antibiotic, and Zollinger-Ellison syndrome. Rabinab Tablet works by blocking the action of the enzyme known as gastric proton pump that is responsible for the production of acid. This helps in reducing the amount of acid produced, heals the ulcers and prevents the formation of new ulcers.

Do not take Rabinab Tablet if you are allergic to any of its contents. Inform your doctor if you have a stomach tumour, liver disease, or if you are due to have Chromogranin A blood test. On long-term treatment, Rabinab Tablet may cause low magnesium levels, vitamin B12 levels, and increase the risk of bone fractures; the doctor may advise regular tests for monitoring your condition. Consult your doctor before starting Rabinab Tablet if you are pregnant or breastfeeding. Rabinab Tablet may cause dizziness and sleepiness, so drive only if you are alert. Rabinab Tablet is not recommended for children as safety has not been established. Avoid consuming alcohol along with Rabinab Tablet as it could lead to increased drowsiness and can elevate the production of stomach acid. Prolonged intake of Rabinab Tablet is linked with a greater risk of Clostridium difficile-associated diarrhoea, so if you develop diarrhoea that does not improve, immediately consult a doctor. Keep your doctor informed about your health condition and medicines to rule out any side-effects.

• Inform your doctor before taking Rabinab Tablet if you are due to have Chromogranin A blood test.
• Rabinab Tablet may cause abnormal blood and liver enzyme values. Inform the person doing the tests that you are taking Rabinab Tablet.